http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0517454-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C315-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
filingDate 1991-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c8a5c1cc45717ce48e77f9cad83663c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a36e679e08929c4b42f683025429ba81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7549e62f5c8c8ec9c21baad5465d20
publicationDate 1993-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0517454-A
titleOfInvention α-Aryl-4- (4,5-dihydro-3,5-dioxo-1,2,4-triazin-2 (3H) -yl) -benzeneacetonitrile derivative
abstract (57) [Summary] [Structure] α-aryl-4- (4,5-dihydro- 3,5-dioxo-1,2,4-triazine-2 (3 H) -yl) -benzeneacetonitrile-6-substituted product [Effect] α-aryl-4- (4,5), which is effective as a therapeutic agent for sporozoites by removing the 6-substituent -Dihydro-3,5-dioxo-1,2,4-triazin-2 (3H) -yl) benzeneacetonitrile is obtained.
priorityDate 1984-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231381713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69491168
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5722
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5802
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID519065
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID519065
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5802

Total number of triples: 40.